Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100408856 | 10040885 | 6 | F | 2014 | 20160829 | 20140327 | 20160831 | PER | US-PFIZER INC-2014083425 | PFIZER | 63.00 | YR | F | Y | 81.63000 | KG | 20160831 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100408856 | 10040885 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 2X/DAY (ONE IN THE MORNING AND TWO AT NIGHT) | 21446 | CAPSULE, HARD | BID | ||||||||
100408856 | 10040885 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 225 MG, 2X/DAY | 21446 | 225 | MG | CAPSULE, HARD | BID | ||||||
100408856 | 10040885 | 3 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
100408856 | 10040885 | 4 | C | ACETAMINOPHEN/HYDROCODONE | ACETAMINOPHENHYDROCODONE | 1 | UNK [HYDROCODONE BITARTRATE10]/[PARACETAMOL 325] | 0 | |||||||||||
100408856 | 10040885 | 5 | C | MORPHINE | MORPHINE | 1 | 30 MG, UNK (30MG ER X1) | 0 | 30 | MG | |||||||||
100408856 | 10040885 | 6 | C | HYDROCODONE | HYDROCODONE | 1 | 325 MG ONCE EVERY FOUR HOURS AS NEEDED | 0 | 325 | MG | |||||||||
100408856 | 10040885 | 7 | C | MS CONTIN | MORPHINE SULFATE | 1 | 30 MG, 2X/DAY | 0 | 30 | MG | PROLONGED-RELEASE TABLET | BID | |||||||
100408856 | 10040885 | 8 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | [HYDROCODONE BITARTRATE 10 MG]/ [PARACETAMOL 325 MG] EVERY 6-8 HOURS AS NEEDED | 0 | TABLET | |||||||||
100408856 | 10040885 | 9 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | 50 MG, 1X/DAY (NIGHTLY) | 0 | 50 | MG | TABLET | QD | ||||||
100408856 | 10040885 | 10 | C | ASPIRIN 81 | ASPIRIN | 1 | 81 MG, UNK (81MG X1) | 0 | 81 | MG | PROLONGED-RELEASE TABLET | ||||||||
100408856 | 10040885 | 11 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Intravenous (not otherwise specified) | 40 MG, UNK (40MG X1) | 0 | 40 | MG | SOLUTION FOR INJECTION | |||||||
100408856 | 10040885 | 12 | C | CALCIUM | CALCIUM | 1 | 600 MG, UNK (600MG X2) | 0 | 600 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
100408856 | 10040885 | 1 | Neuralgia |
100408856 | 10040885 | 2 | Fibromyalgia |
100408856 | 10040885 | 3 | Neuropathy peripheral |
100408856 | 10040885 | 5 | Pain |
100408856 | 10040885 | 6 | Pain |
100408856 | 10040885 | 7 | Pain |
100408856 | 10040885 | 8 | Pain |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
100408856 | 10040885 | Burning sensation | |
100408856 | 10040885 | Neuralgia | |
100408856 | 10040885 | Pain | |
100408856 | 10040885 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |